Treatment of Streptococcus pneumoniae Bacteremia in Sickle Cell Disease

Initial Empiric Antibiotic Selection

The American College of Physicians and Infectious Diseases Society of America recommend initiating empiric treatment with IV ceftriaxone 2g daily plus vancomycin 15-20 mg/kg every 8-12 hours for S. pneumoniae bacteremia in patients with sickle cell disease, until susceptibilities confirm penicillin sensitivity 1, 2
The initial empiric antibiotic selection should include dual therapy with a third-generation cephalosporin, such as ceftriaxone, and vancomycin to cover potential penicillin-resistant and cephalosporin-resistant strains 1

If the isolate is penicillin-susceptible, the American Heart Association recommends switching to penicillin G 2-3 million units IV every 4 hours 2
If the isolate is penicillin-resistant but cephalosporin-susceptible, the American Heart Association recommends continuing high-dose ceftriaxone 2g daily 2
If the isolate is ceftriaxone-resistant, the American Heart Association recommends continuing vancomycin and considering adding rifampin, in consultation with an infectious disease specialist 2

The Infectious Diseases Society of America recommends a minimum of 2 weeks of IV therapy for uncomplicated bacteremia, with criteria for uncomplicated including exclusion of endocarditis, no implanted prostheses, follow-up blood cultures at 2-4 days negative, defervescence within 72 hours, and no metastatic infection sites 3
For complicated bacteremia, the Infectious Diseases Society of America recommends 4-6 weeks of therapy, depending on the extent of infection 3

The American College of Physicians recommends obtaining follow-up blood cultures 2-4 days after initial positive cultures to document clearance of bacteremia 3
The American Heart Association recommends performing echocardiography on all adult patients with bacteremia to exclude endocarditis, with transesophageal echocardiography preferred 3, 2
The Infectious Diseases Society of America recommends assessing for treatment failure if fever persists beyond 72 hours despite appropriate antibiotics, clinical deterioration occurs, or new complications develop 4, 1

The Centers for Disease Control and Prevention recommend continuing penicillin prophylaxis indefinitely after recovery from pneumococcal bacteremia in patients with sickle cell disease, with standard prophylaxis being penicillin V 125 mg twice daily 5, 6
The Centers for Disease Control and Prevention recommend ensuring pneumococcal vaccination status is current and considering revaccination if the last dose was >5 years ago and the patient was <65 years at initial vaccination 5, 6